Illumina Inc

NASDAQ: ILMN
$141.43
+$5.07 (+3.7%)
Closing Price on October 4, 2024

ILMN Stock Chart and Intraday Price

ILMN Stock Data

Asset Type Stock
Exchange NASDAQ
Currency USD
Country USA
Sector LIFE SCIENCES
Industry LABORATORY ANALYTICAL INSTRUMENTS
Address 5200 ILLUMINA WAY, SAN DIEGO, CA, US
Fiscal Year End December
Latest Quarter 12/31/2023
Market Cap 22,325.45M USD
Shares Outstanding 158,900,000
Illumina Inc is a global leader in genomics, offering advanced solutions for DNA sequencing and analysis. Based in San Diego, California, since 1998, Illumina provides a wide range of products, including sequencing and array-based instruments, consumables, and whole-genome sequencing kits. These products cater to genomic research centers, academic institutions, hospitals, and various companies in the biotech and pharmaceutical sectors. Illumina is also pioneering in cancer diagnostics with its multi-cancer early detection test, Galleri, and is developing new technologies for blood-based disease detection and monitoring.

ILMN Articles

Stock spinoffs are a popular corporate strategy for unlocking shareholder value, but one that rarely pays off for investors. Harvard Business Review found half of all spinoffs failed to create any...
Monday's top analyst upgrades and downgrades included Arm, General Electric, Micron Technology and Salesforce.
Friday's top analyst upgrades and downgrades included Agilent, Boeing, General Electric, Lockheed Martin, Meta Platforms, Micron Technology, Redfin, Salesforce, Trade Desk, Unity Software and Workday.
Shares of regional banks took a beating on Monday, but, having survived the day, appeared to be making a partial recovery in premarket trading on Tuesday.
January consumer price index data is due out before markets open on Tuesday. Here's what to watch for.
Investors were cautious Tuesday morning, following the Monday holiday. Crude oil and bitcoin trended higher, but stocks and gold were trading lower.
After a week of modest gains, Friday's premarket session was shaping up as a downer. All three major indexes were trading lower.
Tuesday's top analyst upgrades and downgrades included Accenture, Analog Devices, Apple, Baxter International, Best Buy, Coterra Energy, Emerson Electric, Johnson Controls, Lam Research, Micron...
Monday's top analyst upgrades and downgrades included Accenture, Analog Devices, Baxter International, Best Buy, Coinbase Global, Johnson Controls, Lam Research, Micron Technology and Qualcomm.
Thursday's top analyst upgrades and downgrades included Airbnb, Applied Materials, AutoZone, BorgWarner, Carvana, Dominion Energy, EQT, MongoDB, NRG Energy, PagSeguro Digital, Southwestern Energy,...
Tuesday's additional top analyst upgrades and downgrades were on Bank of New York Mellon, Butterfly Network, Etsy, Ginkgo Bioworks, Illumina, Poshmark and more.
Monday's top analyst upgrades and downgrades included Amgen, CarMax, Centene, CrowdStrike, Intuit, Micron Technology, Microsoft, Nike, NOV, Roblox, Unity Software and Wells Fargo.
Thursday's top analyst upgrades and downgrades included Apple, CSX, Enovix, Healthpeak Properties, Lockheed Martin, Netflix, Philip Morris International, Regions Financial, Riot Blockchain, Rivian...
Friday’s top analyst upgrades and downgrades included Danaher, Exact Sciences, First Majestic Silver, First Solar, Illumina, KB Home, NetApp, Nvidia, Salesforce, Snowflake, Splunk and TechnipFMC.
Monday’s top analyst upgrades and downgrades included Archer Daniels Midland, Crowdstrike, GoodRx, Illumina, Oracle, Payoneer Global, Palo Alto Networks, Playa Hotels, Rivian Automotive,...